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balloon uncrossable lesion in chronic total
occlusionExcimer lasers are pulsed gas lasers that use a mixture of a
rare gas and halogen as the active medium to generate pulses
of short-wavelength, high-energy ultraviolet light. [1] Irradiction
to atherosclerotic coronary artery segments allows the culprit
lesions to transpirate without heat damaging the normal tissues.
We described an effective case of excimer laser coronary atherec-
tomy (ELCA) for a device-uncrossable chronic total occlusion
(CTO) lesion below.
A 77-year-old male was found to have a large ischemic defect and
redistribution in the inferior wall that was revealed by myocardial
perfusion scintigraphy before cerebrovascular surgery. The patient
was suspected to have ischemic heart disease, and was transferred
to our institution. A coronary angiography (CAG) revealed non-
occlusive disease of his left coronary system along with a CTO of
the right coronary artery (RCA) (Fig. 1A); he was diagnosed with si-
lent myocardial ischemia (SMI), and percutaneous coronary interven-
tion (PCI) was performed. We performed PCI for the CTO lesion after
cerebrovascular surgery because we diagnosed stable ischemic heart
disease. A 6 French approach was adopted (JR4.0 guide for the
RCA). An antegrade approach was selected because of a lack of appro-
priate collateral branches for a retrograde approach. A GAIA ﬁrst
guidewire (Asahi Intecc Co. Ltd., Nagoya, Japan), with the support of
an Asahi Corsair microcatheter (also called channel dilator, Asahi
Intecc Co. Ltd., Nagoya, Japan), was crossed into the distal site of the
occluded lesion (Fig. 1B). However, a Corsair microcatheter, Sapphire
II balloon 1.0 × 5.0 mm (Orbusneich Medical, Tokyo, Japan) and
Tornus 2.6Fr (penetration catheter, Asahi Intecc Co. Ltd., Nagoya,
Japan) were not able to pass the lesion. Thereafter, although we
tried mother and child technique [2] and buddy wire technique,
both techniques failed. Eventually, perforation in the distal RCA le-
sion by the guidewires was conﬁrmed (Fig. 1C). However, no ﬁnd-
ings indicated cardiac tamponade and the hemodynamics were not
disrupted; all procedures were terminated because of potent con-
cerns of cardiac tamponade.
After 17 months, a second PCI attempt was performed. Single
right femoral access was obtained, and a 7Fr AL1.0 SH guiding
catheter with side holes (Cordis Corporation, Warren, NJ, USA)
was used. Although a GAIA ﬁrst guidewire, with the support of
an Asahi Corsair microcatheter, was crossed into the distal site of
the occluded lesion similar to a previous procedure, CAG revealed
that the GAIA ﬁrst guidewire was suspected of crossing a pseudo-
lumen. After withdrawing the Corsair microcatheter, Navifocus WR
intravascular ultrasound (IVUS) system (Terumo Corp., Japan) [3]
was performed through the GAIA ﬁrst guidewire in that it was
suspected to be in the pseudo-lumen. Referencing the IVUS im-
ages, a GAIA second guidewire (Asahi Intecc Co. Ltd., Nagoya,
Japan) crossed the CTO lesion through a different pathway by anhttp://dx.doi.org/10.1016/j.ijcha.2015.08.004
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GAIA ﬁrst guidewire revealed that the GAIA second guidewire
was crossing the true-lumen in the CTO lesion (Fig. 2A). Attempts
to cross balloon catheters or penetration catheters for dilatations
or microcatheter failed similarly to previous procedures. An
excimer laser (Spectranetics, Colorado Springs, Co., USA) [1] was
advanced over the GAIA second guidewire; photoablation was
performed. We performed the excimer laser technique with a
Point 9 catheter (Spectranetics, Colorado Springs, Co., USA) at a
maximum energy of 60 ﬂuence and a frequency of 40 Hz. During
each activation of the laser, contrast agent was injected into the
vessel to amplify the disruptive effect of the laser. This successfully
photoablated the lesion which allows the Corsair microcatheter to
advance into the distal RCA (Fig. 2B). The GAIA second guidewire
was diverted to Neo's SION Blue guidewire (Asahi Intecc Co. Ltd.,
Nagoya, Japan) using a Corsair microcatheter. Afterwards, sequential
balloon expansion occurred, and the lesion was then successfully
stented (Fig. 2C).
In this session, although a guidewire crossed into a false-lumen,
this cross allowed us to cross another guidewire into the true-
lumen by an IVUS-guided technique. After we conﬁrmed that the
guidewire was present in true-lumen, we performed the ELCA. A
previous report [4] by Brilakis et al. showed that the use of
Rotablator® was an alternative; however, it was impossible to use
a Rotawire® because it was not realistic in the present case.
The laser catheter was used to have the ability to cross the
heavily calciﬁed CTO lesion that the balloon was not able to
cross. However, the advent of a smaller (0.9 mm tip diameter)
excimer laser coronary catheter (Point 9, Spectranetics Corpora-
tion, USA) allowed us to cross the complex lesions, as described
in the case above.
The Point 9 xenon chloride excimer laser catheter is a pulsed ultravio-
let laser catheter. It differs from longer-wavelength continuous-wave
lasers in that it causes minimal thermal injury to tissue and is capable of
ablating calciﬁed plaque. Early generation 1.6-mm catheters were made
of twelve 100-μm ﬁbers. The 0.9 mm consisted of two rows of 50-μm
ﬁbers arranged concentrically around the PTFE (polyﬂuoroethylene)
walled guide wire tubing [5].
The major ﬁndings of this report are as follows: 1) balloon expan-
sions and stent deployments were successfully achieved by performing
ELCA for a CTO lesion where a balloon or penetration catheter would
not pass or when the procedure was limited to an antegrade approach,
and 2) a PCI guidewire was able to cross the true-lumen by utilizing a
parallel wire technique and IVUS-guided technique. After we con-
ﬁrmed that the PCI guidewire was present in the true-lumen, ELCA
was performed.Funding sources.
None.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. (A) Chronic total occlusion (CTO) of the mid-right coronary artery (RCA) revealed by coronary angiography. (B) Guidewire advanced to distal RCA. (C) Extravasation of contrast
media (arrowhead).
Fig. 2. (A) Presence of guidewire in true-lumen revealed by intravascular ultrasound images (arrow). (B) Irradiction to CTO segments by excimer laser. (C) Post-stent deployment, with
excellent results.
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